Related Experiment Video
Updated: Jul 17, 2025

Method for Efficient Refolding and Purification of Chemoreceptor Ligand Binding Domain
Published on: December 12, 2017
Dynamical characterization and multiple unbinding paths of two PreQ1 ligands in one pocket
Guodong Hu1,2, Yonghong Zhang2, Zhiping Yu1
1Shandong Key Laboratory of Biophysics, Dezhou University, Dezhou 253023, China. xzszhgd@163.com.
This study used molecular dynamics simulations to understand how preQ1 riboswitches bind ligands. Findings reveal key nucleotide interactions and the role of Mg2+ ions, aiding antibiotic drug design.
Area of Science:
- Molecular Biology
- Biophysics
- Computational Chemistry
Background:
- Riboswitches regulate bacterial gene expression via small molecule binding.
- Class 1 preQ1 riboswitch aptamers are crucial models for RNA folding and antibiotic drug targets.
Purpose of the Study:
- To characterize the binding determinants of the preQ1-II riboswitch aptamer to preQ1 ligands.
- To provide insights for designing novel small molecule antibiotics.
Main Methods:
- Conducted 62.4 μs of conventional and enhanced-sampling molecular dynamics (MD) simulations.
- Performed binding free energy decomposition analysis.
- Utilized enhanced sampling simulations to reveal ligand unbinding pathways.
Main Results:
- Identified specific nucleotide interactions (G5, C17, C18, A30, A12, C31) with preQ1 ligands at alpha and beta sites.
- Demonstrated the critical role of Mg2+ ions in stabilizing the binding pocket and facilitating ligand binding.
- Revealed two distinct pathways for alpha site ligand unbinding, influenced by the beta site ligand's presence.
- Observed ligand-induced pre-organization of the riboswitch for ligand entry.
Conclusions:
- The study elucidates the molecular mechanisms of preQ1 riboswitch-ligand interactions.
- Findings offer valuable information for the rational design of potent and specific small molecule antibiotics targeting riboswitches.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Ligand Binding and Linkage
Cooperative Allosteric Transitions
The Equilibrium Binding Constant and Binding Strength
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Ligand-Gated Ion Channel Receptor: Gating Mechanism